The Who’s Teen Cancer Lounge at Sloan Kettering opens

March 18, 2016- by Steven E. Greer MD

The Memorial Sloan Kettering Cancer Center held a press day for its new teen lounge Continue reading

Posted in Memorial Sloan-Kettering, Oncology | Leave a comment

The FDA pathway for biosimilar drug approvals

March 26, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - Generics, FDA | Leave a comment

The Weekly Summary

December 19th – December 25th                                 2016

 In general news, an ISIS-organized deadly attack on a Berlin Christmas square put Angela Merkel Continue reading

Posted in - The Weekly Summary | Leave a comment

The Weekly Summary

December 12th – December 18th                                 2016

In general news, in Cairo, dozens of Christians were slaughtered by radical Islam while in Sunday Mass. Continue reading

Posted in - The Weekly Summary | Leave a comment

Review of combination immunotherapies seen at ASCO 2016

June 22, 2016- interviewed by Steven E. Greer, MD

We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Antoni Ribas, MD discusses cancer drugs targeting the PD1 signaling pathways

March 19, 2013- Interviewed by Steven E. Greer, MD

The upcoming ASCO meeting will be dominated by numerous presentations relating to new Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

BRAF and MEK combos for melanoma

Update October 1, 2015- The FDA approved the use of two drugs, Opdivo and Yervoy, to treat metastatic melanoma, as we first discussed with Dr. Ribas last year.  Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The Weekly Summary

pm-matteo-of-itlayDecember 5th – December 11th                                 2016

In general news, the global populism movement spread as Italy’s pro-establishment Prime Continue reading

Posted in - The Weekly Summary | Leave a comment

Book Review: The Unwinding

theunwindingMarch 13, 2016- by Steven E. Greer, MD

Sometimes, things sit around your house for so long that you forget they are there. I bought Continue reading

Posted in - Reviews, books, devices | 2 Comments

Is Vitamin-D deficiency overdiagnosed?

November 8, 2016- Interviewed by Steven E. Greer, MD

We interviewed JoAnn E. Manson, MD, DrPH, Chief, Division of Preventive Medicine, Brigham Continue reading

Posted in - NEJM, - Policy, CDC, Diabetes and endocrinology, FDA, Harvard, Primary care medicine | Leave a comment

CheckMate 026: Why did Opdivo (nivolumab) fail in NSCLC?

September 1, 2016- Interviewed by Steven E. Greer, MD

In the wake of the news-making failure of CheckMate 026 of Bristol-Myers Squibb’s Opdivo (nivolumab) fail in Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

CBS promotes outrageous pro-coffee research, again

Update May 8, 2016- HBO’s John Oliver focused on this problem of TV news misrepresenting the Continue reading

Posted in - Opinion, - Policy, Cardiology, Primary care medicine, Psychology Psychiatry, Urology | Leave a comment

Changes in plastic surgery training programs

March 3, 2015- Interviewed by Steven E. Greer, MD

In Part 1 of our interview with the new Chairman of Plastic Surgery at NYU, Eduardo Rodriguez, Continue reading

Posted in - Policy, NYU, Plastic surgery | Leave a comment

Ibrance (palbociclib) to treat advanced breast cancer

November 28, 2016- Interviewed by Steven E. Greer, MD

We interviewed Richard Finn, MD about his NEJM Continue reading

Posted in - Biotech, - NEJM, - Pharma, Oncology, UCLA | Leave a comment

Review of immunotherapy and targeted therapy

June 17, 2016- interviewed by Steven E. Greer, MD

We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

How the FDA regulates compounding pharmacies

April 5, 2015- Interviewed by Steven E. Greer, MD

Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the Continue reading

Posted in - Policy, FDA | 1 Comment

Are the new PCSK9 cholesterol lowering drugs worth the high cost?

December 16, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA | Leave a comment

The Daltrey Townshend teenage and young adult cancer center at UCLA

May 4, 2014- Interviewed by Steven E. Greer

More than 20 years ago, Roger Daltrey began forming special cancer units in the UK to treat patients in their teenage Continue reading

Posted in - Opinion, Oncology, Rehab, UCLA | Leave a comment

The Weekly Summary

ohio-state-isis-attackerNovember 28th – December 4th                                 2016

In the general news, an ISIS-inspired lone attacker from Somalia, who became a U.S. citizen Continue reading

Posted in - The Weekly Summary | Leave a comment

The MusiCorps benefit concert 2015

October 16, 2015- by Steven E. Greer, MD

We interviewed the Founder of MusiCorps, Arthur Bloom, and one of the musicians in the band, Continue reading

Posted in - Policy, NIH, Orthopedic surgery, Plastic surgery, Psychology Psychiatry, Trauma Surgery, VA Walter Reed | Leave a comment